Navigation Links
WARFARIN Study Launched to Assess Impact of Genetic Testing in Reducing Hospitalizations and Deaths Caused by Warfarin
Date:3/1/2011

BOTHELL, Wash., March 1, 2011 /PRNewswire/ -- Iverson Genetic Diagnostics, Inc. announced today that the WARFARIN Study (Warfarin Adverse Event Reduction for Adults Receiving Genetic Testing at Therapy Initiation) was initiated in major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events. Warfarin, the most commonly prescribed blood thinner worldwide, causes up to 100,000 serious and unnecessary adverse events every year, including thousands of deaths.  Studies have shown that DNA testing can dramatically improve the safety and effectiveness of warfarin, with estimated savings to the U.S. healthcare system of approximately $1.1 billion.Warfarin is prescribed to 2 million patients in the U.S. annually and approximately 20 million Americans use the drug in total.  Warfarin is difficult to dose as patients respond to it differently according to their genetic makeup -- too much warfarin can result in severe bleeding, and too little can cause clot formation and increased risk of stroke.  In the past, warfarin dosing relied on trial-and-error, which exposed patients to serious medical risks.  Warfarin is the second most frequent cause of drug-related emergency room visits.

Over the past few years, two genetic variants have been identified that predict an individual's response to warfarin.  Using genetic testing to guide physicians in starting warfarin therapy has the potential to reduce deaths, increase overall patient safety and lower national healthcare system costs.  Given the magnitude of these potential improvements in warfarin use, the Centers for Medicare & Medicaid Services (CMS) has authorized the WARFARIN Study to gather data on the potential impact of a pharmacogenetic test to reduce serious bleeding and clotting episodes in pat
'/>"/>

SOURCE Iverson Genetic Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sermo Study shows 70% of Specialists are Ready to Replace Warfarin
2. Data Published in The Lancet Compare Dabigatran Etexilate to Dose-Adjusted Warfarin Across RE-LY® Trial Centers
3. American Stroke Association Late-Breaking Science Report: New Drug as Effective as Warfarin in Preventing Strokes in Atrial Fibrillation Patients With Prior Stroke or TIA
4. New Assessment Quantifies Risks and Benefits of Warfarin Treatment for Atrial Fibrillation
5. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
6. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. ACD Announces Clinical Study Results Using its RNAscope™ Technology
10. Kendle Appoints Martha Feller, PhD, Vice President and Global Head, Study Start-up
11. NewCardio Study Shows CardioBip Detects Recurrent Atrial Fibrillation Earlier and More Reliably than Periodic Holter Monitoring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 2014 Research and Markets has ... Medical X-ray Film Industry Report 2014" report to ... Global And Chinese Medical X-Ray Film Industry ... the current state of the Global medical X-ray film ... The report provides a basic overview of the industry ...
(Date:7/11/2014)... 2014 On Thursday, July ... the Dow Jones Industrial Average finished the day 0.42% lower ... 0.41%. The losses were broad based as eight out of ... Health Care Sector Index ended the day at 711.88, down ... one month. Investor-Edge has initiated coverage on the following equities: ...
(Date:7/11/2014)... , July 11, 2014 Neurelis, Inc. ... ("Biotie") to end the option held by Biotie to ... further development of NRL-1 (intranasal diazepam) for pediatric and ... Over the past year, Biotie has advanced the ... preparation for the pivotal clinical work required for NDA ...
Breaking Medicine Technology:Global and Chinese Medical X-ray Film Industry Report 2014 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
... BEIJING, June 22, 2011 /PRNewswire-Asia-FirstCall/ -- China Medical ... ), a leading China-based advanced in-vitro diagnostic ("IVD") ... GP Medical Technologies Co., Ltd. ("GP Medical"), has ... An Healthcare Investment Ltd. ("Da An Health") to ...
... Millstone Medical Outsourcing announced today that the ... online inventory management system.  After several months of ... password-protected system used by medical device manufacturers to ... of the enhanced inventory management system include increased ...
Cached Medicine Technology:China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health 2China Medical Technologies Announces Strategic Collaboration Between its Subsidiary, GP Medical, and Da An Health 3Millstone Medical Outsourcing Introduces Advanced Version of Online Inventory Management System 2
(Date:7/14/2014)... News) -- Being physically active in middle age appears ... other types of dementia, suggest the findings from two ... physical exercise at various levels, especially in midlife, is ... Mayo Clinic, said in an Alzheimer,s Association news release. ... yet conclusive. More research is needed to determine the ...
(Date:7/14/2014)... Skin M.D. by ... on Monday, July 14th, located at 45 East ... last all week through Saturday, July 19th, with ... welcomed to attend. The business is owned by ... anti-aging, weight loss services, and sells high-end industry ...
(Date:7/14/2014)... The NIH is giving $8 million ... fund a clinical trial on light-based therapy in mesothelioma ... newly-posted article on the research. , Scientists at ... to enroll 102 pleural mesothelioma study participants ... photosensitizing drug prior to surgery. Then half will have ...
(Date:7/14/2014)... “You've probably heard the expression, 'You ... mean?” This question was posed in an article by ... Medical Group’s blog regarding how people should select what ... . , According to the article, individuals who consume ... a high risk of dehydration and consequent negative health ...
(Date:7/14/2014)... Cabin Chiang Mai, Asia’s leading inpatient addiction treatment centre, ... – a free comprehensive aftercare service for clients who ... they live in the world. , The Cabin firmly ... maintain their recovery after successfully completing primary treatment should ... As a chronic disease, addicts in recovery are always ...
Breaking Medicine News(10 mins):Health News:Staying Active May Help Prevent Dementia 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 2Health News:The Cosmetic Medic Announces Grand Opening of New Skin M.D., a Physician-Administered Anti-aging, Skincare, and Weight Loss Practice 3Health News:New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma 2Health News:Drink With Your Mental Health in Mind, Advises an Article by Mental Health America Featured by Western Washington Medical Group 2Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 2Health News:The Cabin Chiang Mai Addiction Rehab Launches Industry-leading Aftercare Service 3
... to prevent heart failure, stroke , WEDNESDAY, Nov. ... status as the best first-line treatment in older ... research concludes. , The thiazide-type diuretic chlorthalidone outshone ... an ACE inhibitor and an alpha-receptor blocker -- ...
... to Release Statewide Data , HARRISBURG, Pa., Nov. 18 Pennsylvania ... children and adults living with autism, according to the Pennsylvania Autism ... , "With the release of this report, Pennsylvania becomes the ... prepare to meet the needs of the rapidly growing population of ...
... , CLEVELAND, Nov. 18 Hospice workers have seen patients ... them. Researchers from the Frances Payne Bolton School of Nursing ... Reserve University will study what drives the dying to resolve ... Mary Jo Prince-Paul from nursing and Julie Exline from arts ...
... captures insects, an innovative new device with nano-sized features developed ... in the blood that have broken off from a tumor. ... tumor cells, or CTCs, can provide critical information for examining ... effectiveness of therapies. Metastasis ...
... common surgical painkillers help cancer cells thrive , WEDNESDAY, ... to growing evidence that morphine and other opiate-based painkillers ... , The papers, scheduled to be presented Wednesday at ... preventing opiates from reaching lung cancer cells reduces cancer ...
... ... Organization is asking for nominations for the 2010 Innovations in Healthcare(SM) ABBY ... Event, on April 28, 2010, in Newport Beach, California. At this event, ... of the toughest problems facing healthcare today, and three will take home ...
Cached Medicine News:Health News:Diuretics Still Best Treatment for High Blood Pressure 2Health News:PA Governor Rendell: New Report Shows Demand for Autism Services will Continue to Rise 2Health News:Research Collaboration Focuses on Unfinished Business at the End of Life 2Health News:UCLA researchers create 'fly paper' to capture circulating cancer cells 2Health News:UCLA researchers create 'fly paper' to capture circulating cancer cells 3Health News:Morphine May Help Tumors Spread in Cancer Patients 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 2Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 3Health News:Nominate Your Favorite Innovative Healthcare Company for the 2010 ABBY Awards 4
PhenoPath Laboratories provides screening, diagnostic, and prognostic testing services to hospitals, physician offices, surgery centers, biopharmaceutical companies and research institutions nationwi...
the LabOne Healthcare Group markets laboratory testing to physicians, patients, managed care companies, self-insured employers, wellness companies and hospitals....
... hemostatic gauze for a variety of inpatient and ... is easy to handle and can be customized ... that are often a challenge faced by obstetricians ... to control bleeding in outpatient procedures such as ...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Medicine Products: